These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 8294393)

  • 1. Possible therapeutic window for serotonin reuptake inhibitors.
    Fichtner CG; Jobe TH; Braun BG
    J Clin Psychiatry; 1994 Jan; 55(1):36-8. PubMed ID: 8294393
    [No Abstract]   [Full Text] [Related]  

  • 2. Fluoxetine and norfluoxetine.
    Mattes JA
    Am J Psychiatry; 1998 Nov; 155(11):1637. PubMed ID: 9812147
    [No Abstract]   [Full Text] [Related]  

  • 3. Fluoxetine responsivity mediated by serum levels, not dose.
    Schwartz EM; Markovitz PJ
    J Clin Psychopharmacol; 1993 Oct; 13(5):363-4. PubMed ID: 8227496
    [No Abstract]   [Full Text] [Related]  

  • 4. Fluoxetine and onset of its therapeutic effect.
    Grey P
    Am J Psychiatry; 1993 Jun; 150(6):984. PubMed ID: 8494082
    [No Abstract]   [Full Text] [Related]  

  • 5. Discussion of fluoxetine and suicidal tendencies.
    Am J Psychiatry; 1990 Nov; 147(11):1571-2. PubMed ID: 2221176
    [No Abstract]   [Full Text] [Related]  

  • 6. Fluoxetine-induced suicidality, serotonin, and seasonality.
    Brewerton TD
    Biol Psychiatry; 1991 Jul; 30(2):190-6. PubMed ID: 1912109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonin and suicidality: the impact of acute fluoxetine administration. I: Serotonin and suicide.
    King RA; Segman RH; Anderson GM
    Isr J Psychiatry Relat Sci; 1994; 31(4):271-9. PubMed ID: 7875951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible monoamine oxidase inhibitor-serotonin uptake inhibitor interaction: fluoxetine clinical data and preclinical findings.
    Beasley CM; Masica DN; Heiligenstein JH; Wheadon DE; Zerbe RL
    J Clin Psychopharmacol; 1993 Oct; 13(5):312-20. PubMed ID: 8227489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poor response to fluoxetine: underlying depression, serotonergic overstimulation, or a "therapeutic window"?
    Cain JW
    J Clin Psychiatry; 1992 Aug; 53(8):272-7. PubMed ID: 1500403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delirium during fluoxetine treatment. A case report.
    Leinonen E; Koponen H; Lepola U
    Ann Clin Psychiatry; 1993 Dec; 5(4):255-7. PubMed ID: 8312983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies for fluoxetine-MAOI combination therapy.
    Peterson GN
    J Clin Psychiatry; 1991 Feb; 52(2):87-8. PubMed ID: 1993642
    [No Abstract]   [Full Text] [Related]  

  • 12. Fluoxetine and suicidal behaviour. Some clinical and theoretical aspects of a controversy.
    Power AC; Cowen PJ
    Br J Psychiatry; 1992 Dec; 161():735-41. PubMed ID: 1306668
    [No Abstract]   [Full Text] [Related]  

  • 13. Acute organic brain syndrome after fluoxetine treatment.
    Singh RK; Gupta AK; Singh B
    Am J Psychiatry; 1995 Feb; 152(2):295-6. PubMed ID: 7840369
    [No Abstract]   [Full Text] [Related]  

  • 14. What constitutes an adequate antidepressant trial for fluoxetine?
    Schweizer E; Rickels K; Amsterdam JD; Fox I; Puzzuoli G; Weise C
    J Clin Psychiatry; 1990 Jan; 51(1):8-11. PubMed ID: 2403998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apathy and indifference in patients on fluvoxamine and fluoxetine.
    Hoehn-Saric R; Lipsey JR; McLeod DR
    J Clin Psychopharmacol; 1990 Oct; 10(5):343-5. PubMed ID: 2124218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluoxetine potentiation by buspirone: three case histories.
    Bakish D
    Can J Psychiatry; 1991 Dec; 36(10):749-50. PubMed ID: 1790522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mania associated with fluoxetine treatment in adolescents.
    Venkataraman S; Naylor MW; King CA
    J Am Acad Child Adolesc Psychiatry; 1992 Mar; 31(2):276-81. PubMed ID: 1564030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of renal and hepatic disease on the pharmacokinetics, renal tolerance, and risk-benefit profile of fluoxetine.
    Bergstrom RF; Beasley CM; Levy NB; Blumenfield M; Lemberger L
    Int Clin Psychopharmacol; 1993; 8(4):261-6. PubMed ID: 8277145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Toxic tricyclic drug plasma level caused by fluoxetine].
    Hambrecht M
    Psychiatr Prax; 1995 Nov; 22(6):252-3. PubMed ID: 8570758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prozac: pros and cons.
    Glod C
    J Psychosoc Nurs Ment Health Serv; 1990 Dec; 28(12):33-4. PubMed ID: 2283599
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.